Andre H Goy

15PUBLICATIONS
119CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursLiquid biopsiesInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 05, 2026
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

|Oct 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Tom van Meerten, Marie José Kersten, Gloria Iacoboni

|Nov 21, 2024
Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas.

Elise A Chong, Elicia Penuel, Ellen B Napier

|Aug 02, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil

|Dec 05, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.

Michael D Jain, Miriam T Jacobs, Feng Gao

|Mar 16, 2023
A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma.

Kristie A Blum, Jeffrey G Supko, Michael B Maris

Pageof 3

Frequent Collaborators

5 joint publications

David Miklos

5 joint publications

Javier Munoz

4 joint publications

Olalekan Oluwole

4 joint publications

Ian W Flinn